Maryland Healthcare Reporter
SEE OTHER BRANDS

The latest health and wellness news from Maryland

Maryland Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Healthcare Reporter.

Press releases published on August 13, 2025

Greywolf Therapeutics begins dosing of the first treatment to target the antigenic source of autoimmunity

Greywolf Therapeutics begins dosing of the first treatment to target the antigenic source of autoimmunity

This is the first ever autoimmunity study to evaluate a potential functional cure that targets the antigenic source – the origin of autoimmune disease The Phase 1/2 study (up to 141 participants) will evaluate the safety, tolerability and efficacy of …

Santhera schließt Vereinbarung mit GEN über den Vertrieb von AGAMREE® (Vamorolon) in der Türkei

Santhera schließt Vereinbarung mit GEN über den Vertrieb von AGAMREE® (Vamorolon) in der Türkei

Pratteln, Schweiz, 13. August 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt die Unterzeichnung einer exklusiven Vereinbarung mit Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) über den Vertrieb und die Vermarktung von AGAMREE® (Vamorolon) in der …

  Santhera Secures Agreement with GEN for the Distribution of AGAMREE® (Vamorolone) in Türkiye

Santhera Secures Agreement with GEN for the Distribution of AGAMREE® (Vamorolone) in Türkiye

Pratteln, Switzerland, 13 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) for the distribution and promotion of AGAMREE® (vamorolone) in Türkiye …

Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering

Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering

BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today …

Global High-Throughput Screening Market to Surpass USD 50.2 Billion by 2029 | MarketsandMarkets™.

Global High-Throughput Screening Market to Surpass USD 50.2 Billion by 2029 | MarketsandMarkets™.

Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- North America Leads Today, Asia Pacific to Record Fastest Growth The global high throughput screening market, valued at US$25.7 billion in 2023, stood at US$28.8 billion in 2024 and is projected to …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions